nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—ovarian cancer—polycystic ovary syndrome	0.539	1	CtDrD
Paclitaxel—BCL2—polycystic ovary syndrome	0.202	0.663	CbGaD
Paclitaxel—CYP19A1—polycystic ovary syndrome	0.103	0.337	CbGaD
Paclitaxel—CYP19A1—follicular fluid—polycystic ovary syndrome	0.00622	0.107	CbGeAlD
Paclitaxel—CYP19A1—corpus luteum—polycystic ovary syndrome	0.00358	0.0616	CbGeAlD
Paclitaxel—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0028	0.0482	CbGeAlD
Paclitaxel—Docetaxel—BCL2—polycystic ovary syndrome	0.00137	1	CrCbGaD
Paclitaxel—Sinus congestion—Metformin—polycystic ovary syndrome	0.00126	0.0372	CcSEcCtD
Paclitaxel—Loose stools—Metformin—polycystic ovary syndrome	0.00114	0.0334	CcSEcCtD
Paclitaxel—Respiratory distress—Metformin—polycystic ovary syndrome	0.00099	0.0291	CcSEcCtD
Paclitaxel—Nail disorder—Metformin—polycystic ovary syndrome	0.00097	0.0285	CcSEcCtD
Paclitaxel—MAP4—embryo—polycystic ovary syndrome	0.000942	0.0162	CbGeAlD
Paclitaxel—Fungal infection—Metformin—polycystic ovary syndrome	0.000814	0.024	CcSEcCtD
Paclitaxel—MAPT—pituitary gland—polycystic ovary syndrome	0.000794	0.0137	CbGeAlD
Paclitaxel—MAPT—adipose tissue—polycystic ovary syndrome	0.000791	0.0136	CbGeAlD
Paclitaxel—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.000776	0.0228	CcSEcCtD
Paclitaxel—Rigors—Metformin—polycystic ovary syndrome	0.00077	0.0227	CcSEcCtD
Paclitaxel—Blood disorder—Metformin—polycystic ovary syndrome	0.000753	0.0221	CcSEcCtD
Paclitaxel—CYP2C9—urine—polycystic ovary syndrome	0.000746	0.0128	CbGeAlD
Paclitaxel—MAP2—embryo—polycystic ovary syndrome	0.000742	0.0128	CbGeAlD
Paclitaxel—NR1I2—endocrine gland—polycystic ovary syndrome	0.000739	0.0127	CbGeAlD
Paclitaxel—Contusion—Metformin—polycystic ovary syndrome	0.000721	0.0212	CcSEcCtD
Paclitaxel—Accidental injury—Metformin—polycystic ovary syndrome	0.000711	0.0209	CcSEcCtD
Paclitaxel—Chest discomfort—Metformin—polycystic ovary syndrome	0.000711	0.0209	CcSEcCtD
Paclitaxel—MAPT—adrenal gland—polycystic ovary syndrome	0.000709	0.0122	CbGeAlD
Paclitaxel—MAP4—uterus—polycystic ovary syndrome	0.000636	0.0109	CbGeAlD
Paclitaxel—BCL2—endometrium—polycystic ovary syndrome	0.000627	0.0108	CbGeAlD
Paclitaxel—MAP4—adipose tissue—polycystic ovary syndrome	0.000622	0.0107	CbGeAlD
Paclitaxel—MAP2—adrenal cortex—polycystic ovary syndrome	0.000608	0.0105	CbGeAlD
Paclitaxel—TUBB1—adipose tissue—polycystic ovary syndrome	0.000608	0.0105	CbGeAlD
Paclitaxel—Neuropathy—Metformin—polycystic ovary syndrome	0.00059	0.0174	CcSEcCtD
Paclitaxel—BCL2—uterus—polycystic ovary syndrome	0.000578	0.00993	CbGeAlD
Paclitaxel—TUBB4A—embryo—polycystic ovary syndrome	0.000574	0.00986	CbGeAlD
Paclitaxel—CYP3A4—urine—polycystic ovary syndrome	0.000569	0.00978	CbGeAlD
Paclitaxel—Lightheadedness—Metformin—polycystic ovary syndrome	0.000563	0.0165	CcSEcCtD
Paclitaxel—MAP4—adrenal gland—polycystic ovary syndrome	0.000558	0.00959	CbGeAlD
Paclitaxel—SLCO1B3—pituitary gland—polycystic ovary syndrome	0.000546	0.0094	CbGeAlD
Paclitaxel—MAP2—endometrium—polycystic ovary syndrome	0.000543	0.00934	CbGeAlD
Paclitaxel—Ear pain—Metformin—polycystic ovary syndrome	0.000535	0.0157	CcSEcCtD
Paclitaxel—MAP4—female gonad—polycystic ovary syndrome	0.00052	0.00894	CbGeAlD
Paclitaxel—MAP4—vagina—polycystic ovary syndrome	0.000517	0.00889	CbGeAlD
Paclitaxel—Nasal congestion—Metformin—polycystic ovary syndrome	0.000501	0.0147	CcSEcCtD
Paclitaxel—Injury—Metformin—polycystic ovary syndrome	0.000497	0.0146	CcSEcCtD
Paclitaxel—MAP2—pituitary gland—polycystic ovary syndrome	0.000491	0.00845	CbGeAlD
Paclitaxel—MAP2—adipose tissue—polycystic ovary syndrome	0.000489	0.00842	CbGeAlD
Paclitaxel—MAP4—endocrine gland—polycystic ovary syndrome	0.000483	0.00831	CbGeAlD
Paclitaxel—Renal impairment—Metformin—polycystic ovary syndrome	0.00048	0.0141	CcSEcCtD
Paclitaxel—BCL2—female gonad—polycystic ovary syndrome	0.000473	0.00813	CbGeAlD
Paclitaxel—TUBB4A—adrenal cortex—polycystic ovary syndrome	0.00047	0.00808	CbGeAlD
Paclitaxel—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000468	0.0138	CcSEcCtD
Paclitaxel—Lethargy—Metformin—polycystic ovary syndrome	0.000466	0.0137	CcSEcCtD
Paclitaxel—Pain in extremity—Metformin—polycystic ovary syndrome	0.000457	0.0134	CcSEcCtD
Paclitaxel—SLCO1B3—vagina—polycystic ovary syndrome	0.000452	0.00778	CbGeAlD
Paclitaxel—TUBB4B—embryo—polycystic ovary syndrome	0.000447	0.00769	CbGeAlD
Paclitaxel—BCL2—endocrine gland—polycystic ovary syndrome	0.000439	0.00756	CbGeAlD
Paclitaxel—MAP2—adrenal gland—polycystic ovary syndrome	0.000439	0.00755	CbGeAlD
Paclitaxel—TUBB—adrenal cortex—polycystic ovary syndrome	0.00043	0.00739	CbGeAlD
Paclitaxel—TUBB2A—adrenal cortex—polycystic ovary syndrome	0.000428	0.00735	CbGeAlD
Paclitaxel—Dehydration—Metformin—polycystic ovary syndrome	0.000425	0.0125	CcSEcCtD
Paclitaxel—SLCO1B3—endocrine gland—polycystic ovary syndrome	0.000423	0.00728	CbGeAlD
Paclitaxel—TUBB6—adrenal cortex—polycystic ovary syndrome	0.000422	0.00725	CbGeAlD
Paclitaxel—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.000421	0.0124	CcSEcCtD
Paclitaxel—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000417	0.0123	CcSEcCtD
Paclitaxel—Breast disorder—Metformin—polycystic ovary syndrome	0.000413	0.0121	CcSEcCtD
Paclitaxel—Cramp muscle—Metformin—polycystic ovary syndrome	0.000411	0.0121	CcSEcCtD
Paclitaxel—MAP2—female gonad—polycystic ovary syndrome	0.000409	0.00704	CbGeAlD
Paclitaxel—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000408	0.012	CcSEcCtD
Paclitaxel—MAP2—vagina—polycystic ovary syndrome	0.000407	0.007	CbGeAlD
Paclitaxel—TUBB2B—endometrium—polycystic ovary syndrome	0.000406	0.00698	CbGeAlD
Paclitaxel—Abdominal distension—Metformin—polycystic ovary syndrome	0.000397	0.0117	CcSEcCtD
Paclitaxel—Influenza—Metformin—polycystic ovary syndrome	0.000395	0.0116	CcSEcCtD
Paclitaxel—Pancreatitis—Metformin—polycystic ovary syndrome	0.000387	0.0114	CcSEcCtD
Paclitaxel—TUBB4A—uterus—polycystic ovary syndrome	0.000387	0.00665	CbGeAlD
Paclitaxel—Sweating increased—Metformin—polycystic ovary syndrome	0.000384	0.0113	CcSEcCtD
Paclitaxel—TUBB—endometrium—polycystic ovary syndrome	0.000384	0.0066	CbGeAlD
Paclitaxel—TUBB2A—endometrium—polycystic ovary syndrome	0.000382	0.00657	CbGeAlD
Paclitaxel—MAP2—endocrine gland—polycystic ovary syndrome	0.000381	0.00655	CbGeAlD
Paclitaxel—TUBB6—endometrium—polycystic ovary syndrome	0.000377	0.00648	CbGeAlD
Paclitaxel—ABCC10—adrenal cortex—polycystic ovary syndrome	0.000369	0.00635	CbGeAlD
Paclitaxel—Neutropenia—Metformin—polycystic ovary syndrome	0.000369	0.0109	CcSEcCtD
Paclitaxel—TUBB2B—pituitary gland—polycystic ovary syndrome	0.000367	0.00631	CbGeAlD
Paclitaxel—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000367	0.0108	CcSEcCtD
Paclitaxel—TUBB4B—adrenal cortex—polycystic ovary syndrome	0.000367	0.0063	CbGeAlD
Paclitaxel—TUBB2B—adipose tissue—polycystic ovary syndrome	0.000366	0.00629	CbGeAlD
Paclitaxel—ABCB11—endocrine gland—polycystic ovary syndrome	0.000365	0.00628	CbGeAlD
Paclitaxel—CYP3A7—endocrine gland—polycystic ovary syndrome	0.000357	0.00614	CbGeAlD
Paclitaxel—TUBB—uterus—polycystic ovary syndrome	0.000354	0.00608	CbGeAlD
Paclitaxel—TUBB2A—uterus—polycystic ovary syndrome	0.000352	0.00605	CbGeAlD
Paclitaxel—Infestation—Metformin—polycystic ovary syndrome	0.000352	0.0103	CcSEcCtD
Paclitaxel—Infestation NOS—Metformin—polycystic ovary syndrome	0.000352	0.0103	CcSEcCtD
Paclitaxel—TUBB—pituitary gland—polycystic ovary syndrome	0.000347	0.00597	CbGeAlD
Paclitaxel—TUBB6—uterus—polycystic ovary syndrome	0.000347	0.00597	CbGeAlD
Paclitaxel—TUBB—adipose tissue—polycystic ovary syndrome	0.000346	0.00595	CbGeAlD
Paclitaxel—TUBB2A—pituitary gland—polycystic ovary syndrome	0.000346	0.00594	CbGeAlD
Paclitaxel—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000345	0.0101	CcSEcCtD
Paclitaxel—TUBB2A—adipose tissue—polycystic ovary syndrome	0.000344	0.00592	CbGeAlD
Paclitaxel—TUBB6—pituitary gland—polycystic ovary syndrome	0.000341	0.00586	CbGeAlD
Paclitaxel—TUBB6—adipose tissue—polycystic ovary syndrome	0.000339	0.00584	CbGeAlD
Paclitaxel—TUBB4A—adrenal gland—polycystic ovary syndrome	0.000339	0.00583	CbGeAlD
Paclitaxel—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000333	0.00979	CcSEcCtD
Paclitaxel—ABCC10—endometrium—polycystic ovary syndrome	0.00033	0.00567	CbGeAlD
Paclitaxel—TUBB2B—adrenal gland—polycystic ovary syndrome	0.000328	0.00564	CbGeAlD
Paclitaxel—TUBB4B—endometrium—polycystic ovary syndrome	0.000327	0.00563	CbGeAlD
Paclitaxel—Bradycardia—Metformin—polycystic ovary syndrome	0.000322	0.00946	CcSEcCtD
Paclitaxel—Rhinitis—Metformin—polycystic ovary syndrome	0.000317	0.00931	CcSEcCtD
Paclitaxel—TUBB4A—female gonad—polycystic ovary syndrome	0.000316	0.00544	CbGeAlD
Paclitaxel—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000314	0.00924	CcSEcCtD
Paclitaxel—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000311	0.00915	CcSEcCtD
Paclitaxel—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00031	0.00913	CcSEcCtD
Paclitaxel—TUBB—adrenal gland—polycystic ovary syndrome	0.00031	0.00534	CbGeAlD
Paclitaxel—TUBB2A—adrenal gland—polycystic ovary syndrome	0.000309	0.00531	CbGeAlD
Paclitaxel—TUBB2B—female gonad—polycystic ovary syndrome	0.000306	0.00526	CbGeAlD
Paclitaxel—TUBB6—adrenal gland—polycystic ovary syndrome	0.000304	0.00524	CbGeAlD
Paclitaxel—TUBB2B—vagina—polycystic ovary syndrome	0.000304	0.00523	CbGeAlD
Paclitaxel—ABCC10—uterus—polycystic ovary syndrome	0.000304	0.00523	CbGeAlD
Paclitaxel—TUBB4B—uterus—polycystic ovary syndrome	0.000302	0.00519	CbGeAlD
Paclitaxel—ABCC10—pituitary gland—polycystic ovary syndrome	0.000298	0.00513	CbGeAlD
Paclitaxel—ABCC10—adipose tissue—polycystic ovary syndrome	0.000297	0.00511	CbGeAlD
Paclitaxel—TUBB4B—pituitary gland—polycystic ovary syndrome	0.000296	0.00509	CbGeAlD
Paclitaxel—Eye disorder—Metformin—polycystic ovary syndrome	0.000295	0.00868	CcSEcCtD
Paclitaxel—TUBB4B—adipose tissue—polycystic ovary syndrome	0.000295	0.00507	CbGeAlD
Paclitaxel—TUBB4A—endocrine gland—polycystic ovary syndrome	0.000294	0.00506	CbGeAlD
Paclitaxel—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000293	0.00862	CcSEcCtD
Paclitaxel—Flushing—Metformin—polycystic ovary syndrome	0.000293	0.00862	CcSEcCtD
Paclitaxel—TUBB—female gonad—polycystic ovary syndrome	0.000289	0.00498	CbGeAlD
Paclitaxel—TUBB2A—female gonad—polycystic ovary syndrome	0.000288	0.00495	CbGeAlD
Paclitaxel—TUBB—vagina—polycystic ovary syndrome	0.000288	0.00495	CbGeAlD
Paclitaxel—Angiopathy—Metformin—polycystic ovary syndrome	0.000287	0.00843	CcSEcCtD
Paclitaxel—TUBB2A—vagina—polycystic ovary syndrome	0.000286	0.00492	CbGeAlD
Paclitaxel—Immune system disorder—Metformin—polycystic ovary syndrome	0.000285	0.00839	CcSEcCtD
Paclitaxel—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000285	0.00837	CcSEcCtD
Paclitaxel—TUBB2B—endocrine gland—polycystic ovary syndrome	0.000284	0.00489	CbGeAlD
Paclitaxel—TUBB6—female gonad—polycystic ovary syndrome	0.000284	0.00488	CbGeAlD
Paclitaxel—Chills—Metformin—polycystic ovary syndrome	0.000283	0.00833	CcSEcCtD
Paclitaxel—TUBB6—vagina—polycystic ovary syndrome	0.000282	0.00485	CbGeAlD
Paclitaxel—CYP19A1—endometrium—polycystic ovary syndrome	0.000277	0.00477	CbGeAlD
Paclitaxel—Erythema—Metformin—polycystic ovary syndrome	0.000275	0.00809	CcSEcCtD
Paclitaxel—Malnutrition—Metformin—polycystic ovary syndrome	0.000275	0.00809	CcSEcCtD
Paclitaxel—Flatulence—Metformin—polycystic ovary syndrome	0.000271	0.00797	CcSEcCtD
Paclitaxel—Dysgeusia—Metformin—polycystic ovary syndrome	0.000269	0.00792	CcSEcCtD
Paclitaxel—TUBB2A—endocrine gland—polycystic ovary syndrome	0.000268	0.0046	CbGeAlD
Paclitaxel—ABCC10—adrenal gland—polycystic ovary syndrome	0.000267	0.00458	CbGeAlD
Paclitaxel—TUBB4B—adrenal gland—polycystic ovary syndrome	0.000265	0.00455	CbGeAlD
Paclitaxel—Muscle spasms—Metformin—polycystic ovary syndrome	0.000264	0.00777	CcSEcCtD
Paclitaxel—TUBB6—endocrine gland—polycystic ovary syndrome	0.000264	0.00454	CbGeAlD
Paclitaxel—ABCC1—adrenal cortex—polycystic ovary syndrome	0.000261	0.00449	CbGeAlD
Paclitaxel—Vision blurred—Metformin—polycystic ovary syndrome	0.000259	0.00762	CcSEcCtD
Paclitaxel—Tremor—Metformin—polycystic ovary syndrome	0.000258	0.00758	CcSEcCtD
Paclitaxel—CYP19A1—uterus—polycystic ovary syndrome	0.000256	0.0044	CbGeAlD
Paclitaxel—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000255	0.0075	CcSEcCtD
Paclitaxel—CYP19A1—adipose tissue—polycystic ovary syndrome	0.00025	0.0043	CbGeAlD
Paclitaxel—ABCC10—female gonad—polycystic ovary syndrome	0.000249	0.00427	CbGeAlD
Paclitaxel—Malaise—Metformin—polycystic ovary syndrome	0.000248	0.00729	CcSEcCtD
Paclitaxel—ABCC10—vagina—polycystic ovary syndrome	0.000247	0.00425	CbGeAlD
Paclitaxel—TUBB4B—female gonad—polycystic ovary syndrome	0.000247	0.00424	CbGeAlD
Paclitaxel—Syncope—Metformin—polycystic ovary syndrome	0.000247	0.00725	CcSEcCtD
Paclitaxel—TUBB4B—vagina—polycystic ovary syndrome	0.000245	0.00422	CbGeAlD
Paclitaxel—Palpitations—Metformin—polycystic ovary syndrome	0.000243	0.00715	CcSEcCtD
Paclitaxel—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000242	0.00711	CcSEcCtD
Paclitaxel—CYP1B1—uterus—polycystic ovary syndrome	0.000239	0.00411	CbGeAlD
Paclitaxel—Hypertension—Metformin—polycystic ovary syndrome	0.000237	0.00698	CcSEcCtD
Paclitaxel—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000235	0.00403	CbGeAlD
Paclitaxel—Chest pain—Metformin—polycystic ovary syndrome	0.000234	0.00688	CcSEcCtD
Paclitaxel—Myalgia—Metformin—polycystic ovary syndrome	0.000234	0.00688	CcSEcCtD
Paclitaxel—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000234	0.00402	CbGeAlD
Paclitaxel—ABCC1—endometrium—polycystic ovary syndrome	0.000233	0.00401	CbGeAlD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000232	0.00684	CcSEcCtD
Paclitaxel—Discomfort—Metformin—polycystic ovary syndrome	0.000231	0.0068	CcSEcCtD
Paclitaxel—ABCC10—endocrine gland—polycystic ovary syndrome	0.000231	0.00397	CbGeAlD
Paclitaxel—TUBB4B—endocrine gland—polycystic ovary syndrome	0.000229	0.00395	CbGeAlD
Paclitaxel—Oedema—Metformin—polycystic ovary syndrome	0.000224	0.0066	CcSEcCtD
Paclitaxel—CYP19A1—adrenal gland—polycystic ovary syndrome	0.000224	0.00386	CbGeAlD
Paclitaxel—Infection—Metformin—polycystic ovary syndrome	0.000223	0.00656	CcSEcCtD
Paclitaxel—Shock—Metformin—polycystic ovary syndrome	0.000221	0.00649	CcSEcCtD
Paclitaxel—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00022	0.00647	CcSEcCtD
Paclitaxel—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00022	0.00646	CcSEcCtD
Paclitaxel—Skin disorder—Metformin—polycystic ovary syndrome	0.000218	0.00641	CcSEcCtD
Paclitaxel—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000217	0.00638	CcSEcCtD
Paclitaxel—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000216	0.00372	CbGeAlD
Paclitaxel—ABCC1—uterus—polycystic ovary syndrome	0.000215	0.0037	CbGeAlD
Paclitaxel—ABCC2—adrenal gland—polycystic ovary syndrome	0.000214	0.00368	CbGeAlD
Paclitaxel—Anorexia—Metformin—polycystic ovary syndrome	0.000214	0.00629	CcSEcCtD
Paclitaxel—ABCC1—pituitary gland—polycystic ovary syndrome	0.000211	0.00363	CbGeAlD
Paclitaxel—ABCC1—adipose tissue—polycystic ovary syndrome	0.00021	0.00361	CbGeAlD
Paclitaxel—Hypotension—Metformin—polycystic ovary syndrome	0.00021	0.00617	CcSEcCtD
Paclitaxel—CYP1B1—adrenal gland—polycystic ovary syndrome	0.00021	0.0036	CbGeAlD
Paclitaxel—CYP19A1—female gonad—polycystic ovary syndrome	0.000209	0.0036	CbGeAlD
Paclitaxel—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000204	0.00601	CcSEcCtD
Paclitaxel—Paraesthesia—Metformin—polycystic ovary syndrome	0.000201	0.00593	CcSEcCtD
Paclitaxel—Dyspnoea—Metformin—polycystic ovary syndrome	0.0002	0.00588	CcSEcCtD
Paclitaxel—Somnolence—Metformin—polycystic ovary syndrome	0.000199	0.00587	CcSEcCtD
Paclitaxel—CYP2C8—endometrium—polycystic ovary syndrome	0.000199	0.00341	CbGeAlD
Paclitaxel—Dyspepsia—Metformin—polycystic ovary syndrome	0.000198	0.00581	CcSEcCtD
Paclitaxel—CYP1B1—female gonad—polycystic ovary syndrome	0.000195	0.00336	CbGeAlD
Paclitaxel—Decreased appetite—Metformin—polycystic ovary syndrome	0.000195	0.00574	CcSEcCtD
Paclitaxel—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000194	0.00334	CbGeAlD
Paclitaxel—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000194	0.0057	CcSEcCtD
Paclitaxel—Fatigue—Metformin—polycystic ovary syndrome	0.000193	0.00569	CcSEcCtD
Paclitaxel—ABCG2—endometrium—polycystic ovary syndrome	0.000193	0.00332	CbGeAlD
Paclitaxel—Constipation—Metformin—polycystic ovary syndrome	0.000192	0.00564	CcSEcCtD
Paclitaxel—ABCC1—adrenal gland—polycystic ovary syndrome	0.000189	0.00324	CbGeAlD
Paclitaxel—ABCC2—endocrine gland—polycystic ovary syndrome	0.000186	0.00319	CbGeAlD
Paclitaxel—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000185	0.00544	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000183	0.0054	CcSEcCtD
Paclitaxel—CYP1B1—endocrine gland—polycystic ovary syndrome	0.000182	0.00313	CbGeAlD
Paclitaxel—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00018	0.00309	CbGeAlD
Paclitaxel—Urticaria—Metformin—polycystic ovary syndrome	0.000178	0.00524	CcSEcCtD
Paclitaxel—ABCG2—uterus—polycystic ovary syndrome	0.000178	0.00306	CbGeAlD
Paclitaxel—Abdominal pain—Metformin—polycystic ovary syndrome	0.000177	0.00522	CcSEcCtD
Paclitaxel—ABCC1—female gonad—polycystic ovary syndrome	0.000176	0.00302	CbGeAlD
Paclitaxel—ABCC1—vagina—polycystic ovary syndrome	0.000175	0.003	CbGeAlD
Paclitaxel—ABCG2—pituitary gland—polycystic ovary syndrome	0.000175	0.003	CbGeAlD
Paclitaxel—ABCG2—adipose tissue—polycystic ovary syndrome	0.000174	0.00299	CbGeAlD
Paclitaxel—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000162	0.00278	CbGeAlD
Paclitaxel—Asthenia—Metformin—polycystic ovary syndrome	0.000161	0.00473	CcSEcCtD
Paclitaxel—Pruritus—Metformin—polycystic ovary syndrome	0.000159	0.00467	CcSEcCtD
Paclitaxel—ABCG2—adrenal gland—polycystic ovary syndrome	0.000156	0.00268	CbGeAlD
Paclitaxel—Diarrhoea—Metformin—polycystic ovary syndrome	0.000154	0.00451	CcSEcCtD
Paclitaxel—CYP2C8—vagina—polycystic ovary syndrome	0.000149	0.00256	CbGeAlD
Paclitaxel—Dizziness—Metformin—polycystic ovary syndrome	0.000148	0.00436	CcSEcCtD
Paclitaxel—ABCG2—female gonad—polycystic ovary syndrome	0.000146	0.0025	CbGeAlD
Paclitaxel—ABCG2—vagina—polycystic ovary syndrome	0.000145	0.00249	CbGeAlD
Paclitaxel—Vomiting—Metformin—polycystic ovary syndrome	0.000143	0.0042	CcSEcCtD
Paclitaxel—Rash—Metformin—polycystic ovary syndrome	0.000141	0.00416	CcSEcCtD
Paclitaxel—Dermatitis—Metformin—polycystic ovary syndrome	0.000141	0.00416	CcSEcCtD
Paclitaxel—Headache—Metformin—polycystic ovary syndrome	0.000141	0.00413	CcSEcCtD
Paclitaxel—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000139	0.00239	CbGeAlD
Paclitaxel—CYP3A5—female gonad—polycystic ovary syndrome	0.000135	0.00232	CbGeAlD
Paclitaxel—CYP3A5—vagina—polycystic ovary syndrome	0.000134	0.00231	CbGeAlD
Paclitaxel—Nausea—Metformin—polycystic ovary syndrome	0.000133	0.00392	CcSEcCtD
Paclitaxel—ABCB1—embryo—polycystic ovary syndrome	0.00013	0.00224	CbGeAlD
Paclitaxel—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000126	0.00216	CbGeAlD
Paclitaxel—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000124	0.00213	CbGeAlD
Paclitaxel—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000107	0.00183	CbGeAlD
Paclitaxel—ABCB1—endometrium—polycystic ovary syndrome	9.52e-05	0.00164	CbGeAlD
Paclitaxel—CYP3A4—endocrine gland—polycystic ovary syndrome	9.43e-05	0.00162	CbGeAlD
Paclitaxel—ABCB1—uterus—polycystic ovary syndrome	8.77e-05	0.00151	CbGeAlD
Paclitaxel—ABCB1—pituitary gland—polycystic ovary syndrome	8.62e-05	0.00148	CbGeAlD
Paclitaxel—ABCB1—adipose tissue—polycystic ovary syndrome	8.58e-05	0.00148	CbGeAlD
Paclitaxel—ABCB1—adrenal gland—polycystic ovary syndrome	7.7e-05	0.00132	CbGeAlD
Paclitaxel—ABCB1—female gonad—polycystic ovary syndrome	7.18e-05	0.00123	CbGeAlD
Paclitaxel—ABCB1—vagina—polycystic ovary syndrome	7.13e-05	0.00123	CbGeAlD
Paclitaxel—ABCB1—endocrine gland—polycystic ovary syndrome	6.67e-05	0.00115	CbGeAlD
Paclitaxel—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	6.49e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	6.49e-06	0.000105	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CYP19A1—polycystic ovary syndrome	6.48e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NAMPT—polycystic ovary syndrome	6.48e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.45e-06	0.000104	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP11A1—polycystic ovary syndrome	6.4e-06	0.000103	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	6.37e-06	0.000103	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.36e-06	0.000103	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SRD5A1—polycystic ovary syndrome	6.33e-06	0.000102	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	6.31e-06	0.000102	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	6.29e-06	0.000102	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	6.29e-06	0.000101	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKR1C3—polycystic ovary syndrome	6.28e-06	0.000101	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IRS1—polycystic ovary syndrome	6.27e-06	0.000101	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	6.25e-06	0.000101	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	6.24e-06	0.000101	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	6.22e-06	0.0001	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	6.19e-06	9.99e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	6.19e-06	9.98e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP17A1—polycystic ovary syndrome	6.18e-06	9.98e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	6.16e-06	9.93e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—GNAS—polycystic ovary syndrome	6.15e-06	9.93e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	6.14e-06	9.91e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	6.14e-06	9.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	6.09e-06	9.82e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKR1C3—polycystic ovary syndrome	6.05e-06	9.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—STAR—polycystic ovary syndrome	6.04e-06	9.75e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.97e-06	9.64e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP17A1—polycystic ovary syndrome	5.95e-06	9.61e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	5.93e-06	9.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	5.92e-06	9.55e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PRL—polycystic ovary syndrome	5.9e-06	9.53e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	5.9e-06	9.52e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—NCOR1—polycystic ovary syndrome	5.86e-06	9.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	5.85e-06	9.44e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	5.83e-06	9.4e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	5.82e-06	9.39e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT2—polycystic ovary syndrome	5.8e-06	9.36e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—GNAS—polycystic ovary syndrome	5.79e-06	9.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	5.77e-06	9.32e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	5.75e-06	9.29e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—CYP1A1—polycystic ovary syndrome	5.55e-06	8.96e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	5.52e-06	8.91e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—NCOR1—polycystic ovary syndrome	5.51e-06	8.9e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	5.5e-06	8.88e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	5.45e-06	8.8e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	5.44e-06	8.78e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	5.42e-06	8.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	5.41e-06	8.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	5.41e-06	8.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	5.41e-06	8.73e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HMMR—polycystic ovary syndrome	5.39e-06	8.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	5.37e-06	8.66e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TH—polycystic ovary syndrome	5.35e-06	8.63e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TH—polycystic ovary syndrome	5.33e-06	8.6e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	5.29e-06	8.53e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—STAR—polycystic ovary syndrome	5.26e-06	8.5e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	5.26e-06	8.49e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—CYP1A1—polycystic ovary syndrome	5.23e-06	8.44e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—SLC2A4—polycystic ovary syndrome	5.2e-06	8.4e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	5.18e-06	8.36e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—MTHFR—polycystic ovary syndrome	5.18e-06	8.36e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	5.16e-06	8.32e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TH—polycystic ovary syndrome	5.15e-06	8.31e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HSD3B1—polycystic ovary syndrome	5.14e-06	8.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	5.12e-06	8.26e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.08e-06	8.2e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	5.03e-06	8.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	5.02e-06	8.1e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—SLC2A4—polycystic ovary syndrome	5.01e-06	8.09e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NCOR1—polycystic ovary syndrome	4.95e-06	7.98e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	4.92e-06	7.94e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—MTHFR—polycystic ovary syndrome	4.87e-06	7.86e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	4.87e-06	7.86e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	4.86e-06	7.85e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRG1—polycystic ovary syndrome	4.85e-06	7.83e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.81e-06	7.77e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	4.71e-06	7.61e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP19A1—polycystic ovary syndrome	4.71e-06	7.6e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	4.71e-06	7.59e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	4.69e-06	7.57e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TH—polycystic ovary syndrome	4.69e-06	7.56e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	4.69e-06	7.56e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TH—polycystic ovary syndrome	4.65e-06	7.5e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	4.58e-06	7.39e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	4.56e-06	7.37e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	4.56e-06	7.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	4.52e-06	7.29e-05	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—IL6—polycystic ovary syndrome	4.5e-06	7.27e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	4.48e-06	7.22e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	4.44e-06	7.16e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	4.42e-06	7.13e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	4.4e-06	7.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	4.38e-06	7.07e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MTHFR—polycystic ovary syndrome	4.37e-06	7.05e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	4.37e-06	7.05e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	4.35e-06	7.02e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	4.29e-06	6.92e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	4.28e-06	6.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	4.28e-06	6.91e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	4.25e-06	6.86e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	4.23e-06	6.82e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—GNAS—polycystic ovary syndrome	4.21e-06	6.79e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PPARG—polycystic ovary syndrome	4.2e-06	6.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	4.18e-06	6.75e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	4.17e-06	6.74e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	4.16e-06	6.71e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IRS2—polycystic ovary syndrome	4.16e-06	6.71e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	4.14e-06	6.68e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—POMC—polycystic ovary syndrome	4.14e-06	6.68e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.13e-06	6.67e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—INS—polycystic ovary syndrome	4.12e-06	6.65e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—LHB—polycystic ovary syndrome	4.08e-06	6.59e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	4.08e-06	6.59e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—NCOR1—polycystic ovary syndrome	4.01e-06	6.47e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	3.99e-06	6.44e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	3.95e-06	6.38e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PPARG—polycystic ovary syndrome	3.95e-06	6.38e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	3.94e-06	6.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	3.94e-06	6.36e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	3.93e-06	6.34e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.92e-06	6.32e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—POMC—polycystic ovary syndrome	3.9e-06	6.29e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	3.88e-06	6.26e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—INS—polycystic ovary syndrome	3.88e-06	6.25e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	3.86e-06	6.24e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	3.83e-06	6.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	3.81e-06	6.15e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	3.81e-06	6.15e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—CYP1A1—polycystic ovary syndrome	3.8e-06	6.13e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	3.79e-06	6.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	3.73e-06	6.02e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	3.68e-06	5.93e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	3.66e-06	5.91e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	3.66e-06	5.91e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	3.64e-06	5.88e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.64e-06	5.87e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IRS1—polycystic ovary syndrome	3.63e-06	5.86e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	3.62e-06	5.84e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	3.61e-06	5.83e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	3.61e-06	5.83e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.59e-06	5.79e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	3.59e-06	5.79e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	3.56e-06	5.74e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—MTHFR—polycystic ovary syndrome	3.54e-06	5.71e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—INS—polycystic ovary syndrome	3.48e-06	5.61e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	3.46e-06	5.58e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	3.44e-06	5.56e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	3.42e-06	5.53e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	3.41e-06	5.51e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	3.4e-06	5.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	3.36e-06	5.42e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT2—polycystic ovary syndrome	3.36e-06	5.42e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TH—polycystic ovary syndrome	3.36e-06	5.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	3.32e-06	5.36e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	3.32e-06	5.36e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	3.27e-06	5.27e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	3.24e-06	5.23e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	3.22e-06	5.2e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	3.22e-06	5.19e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	3.19e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	3.19e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	3.19e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	3.15e-06	5.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	3.1e-06	5.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	3.07e-06	4.96e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	2.98e-06	4.81e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	2.98e-06	4.81e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	2.97e-06	4.8e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	2.97e-06	4.79e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	2.96e-06	4.78e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	2.94e-06	4.75e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	2.94e-06	4.75e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	2.93e-06	4.73e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—POMC—polycystic ovary syndrome	2.93e-06	4.72e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—INS—polycystic ovary syndrome	2.92e-06	4.72e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.92e-06	4.72e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—INS—polycystic ovary syndrome	2.91e-06	4.7e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TH—polycystic ovary syndrome	2.91e-06	4.69e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.89e-06	4.67e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	2.87e-06	4.63e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	2.83e-06	4.57e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	2.83e-06	4.57e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—INS—polycystic ovary syndrome	2.82e-06	4.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	2.78e-06	4.48e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.76e-06	4.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	2.74e-06	4.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	2.74e-06	4.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	2.66e-06	4.29e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—IL6—polycystic ovary syndrome	2.62e-06	4.23e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	2.61e-06	4.22e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	2.61e-06	4.21e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	2.59e-06	4.18e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—POMC—polycystic ovary syndrome	2.58e-06	4.16e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—INS—polycystic ovary syndrome	2.56e-06	4.13e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	2.55e-06	4.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—INS—polycystic ovary syndrome	2.54e-06	4.1e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TH—polycystic ovary syndrome	2.53e-06	4.09e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	2.51e-06	4.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	2.48e-06	4e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	2.46e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	2.46e-06	3.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	2.38e-06	3.84e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	2.37e-06	3.83e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TH—polycystic ovary syndrome	2.37e-06	3.82e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	2.32e-06	3.74e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	2.31e-06	3.72e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	2.3e-06	3.72e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	2.26e-06	3.65e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	2.19e-06	3.54e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	2.16e-06	3.49e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	2.14e-06	3.46e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	2.12e-06	3.42e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.07e-06	3.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.05e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2e-06	3.23e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	1.97e-06	3.18e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.97e-06	3.17e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.94e-06	3.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	1.93e-06	3.12e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	1.87e-06	3.02e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	1.87e-06	3.01e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	1.85e-06	2.98e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	1.84e-06	2.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—INS—polycystic ovary syndrome	1.84e-06	2.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.83e-06	2.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.8e-06	2.91e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	1.75e-06	2.82e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	1.74e-06	2.81e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	1.63e-06	2.63e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	1.62e-06	2.62e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	1.6e-06	2.58e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—INS—polycystic ovary syndrome	1.59e-06	2.57e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.56e-06	2.52e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—IL6—polycystic ovary syndrome	1.52e-06	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.52e-06	2.45e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.43e-06	2.3e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	1.41e-06	2.28e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—POMC—polycystic ovary syndrome	1.39e-06	2.25e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—INS—polycystic ovary syndrome	1.39e-06	2.24e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.32e-06	2.13e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.3e-06	2.1e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.29e-06	2.09e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.27e-06	2.06e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.21e-06	1.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.15e-06	1.86e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.07e-06	1.73e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	8.7e-07	1.4e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	8.58e-07	1.38e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—INS—polycystic ovary syndrome	8.53e-07	1.38e-05	CbGpPWpGaD
